Mitochondrial Capacity in Pregnant Women
Mito Moms
The Effect of Physical Activity on in Vivo and in Vitro Mitochondrial Capacity in Pregnant Women
1 other identifier
observational
20
1 country
1
Brief Summary
This Pilot \& Feasibility study will test the hypothesis that pregnant women who are more active will have better functioning mitochondria in vivo (higher ATPmax, via 31P-MRS), which will be positively related to maternal and infant mitochondrial function in vitro (higher oxygen consumption rates in primary myotubes and umbilical cord derived mesenchymal stem cells, respectively). Twenty pregnant women (10 active and 10 sedentary) will be recruited in the first trimester of pregnancy determined from self-reported physical activity and assessment by activity monitors. Placental biospecimens will be collected during delivery for other molecular mitochondrial analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 19, 2018
CompletedFirst Submitted
Initial submission to the registry
March 29, 2018
CompletedFirst Posted
Study publicly available on registry
April 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 11, 2020
CompletedSeptember 27, 2022
September 1, 2022
1.9 years
March 29, 2018
September 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Infant in vitro mitochondrial capacity (by oxygen consumption rate)
Infant in vitro mitochondrial capacity measured by oxygen consumption rates in umbilical cord derived mesenchymal stem cells at delivery
1 day
Secondary Outcomes (2)
Relationship between in vivo mitochondrial capacity and infant in vitro mitochondrial capacity (by oxygen consumption rates)
About 20 weeks
Relationship between in vivo mitochondrial capacity and maternal in vitro mitochondrial capacity (by oxygen consumption rate)
About 15 weeks
Study Arms (2)
Active
Physically active will be defined by self-report and confirmed by step counts \>8,000 per day from activity monitoring.
Sedentary
Sedentary lifestyle will be defined by self-report and confirmed by step counts \<5,000 per day from activity monitoring.
Interventions
No behavioral intervention included but the exposure is level of physical activity. Individuals in the Active group will be categorized by their own routine physical activity levels.
No behavioral intervention included but the exposure is level of physical activity. Individuals in the Sedentary group will be categorized by their own routine physical activity levels.
Eligibility Criteria
Healthy women that are classified as either physically active or sedentary in early pregnancy.
You may qualify if:
- Pregnant female
- BMI between 18.5 kg/m2 and 30.0 kg/m2 prior to the current pregnancy (determined by self report and confirmation of pregravid BMI of the index pregnancy from the prenatal record)
- Medically cleared for participation in the study by primary care obstetrician or midwife
- Medically cleared for participation by the Medical Investigator
- Medical record release (prenatal record, hospital delivery record) for study staff to access information in the medical record related to the current and if applicable, the prior pregnancy.
You may not qualify if:
- Risk of early delivery (eg. history of preterm birth, spontaneous abortion, evidence of gestational hypertension (SBP \>160 mmHg \& DBP \>110 mmHg) or pre-eclampsia in the current pregnancy)
- History of intrauterine growth-restriction
- Persistent second- or third-trimester bleeding
- Placenta previa after 26 weeks gestation
- Incompetent cervix or cerclage
- Severe anemia
- High-order pregnancy (e.g. triplets)
- Family history of diabetes
- Heart or lung disease
- HIV or AIDS (self-reported)
- Individuals with contraindication to magnetic resonance spectroscopy such as having magnetic metallic objects in their body
- Unwillingness for placental biospecimens to be collected at delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Related Links
Biospecimen
Placental biospecimens (placenta, umbilical cord, cord blood). Leg muscle tissue.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leanne M Redman, PhD
Pennington Biomedical Research Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 29, 2018
First Posted
April 5, 2018
Study Start
March 19, 2018
Primary Completion
February 11, 2020
Study Completion
February 11, 2020
Last Updated
September 27, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share